Filing Details
- Accession Number:
- 0001181431-12-026995
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-02 16:00:28
- Reporting Period:
- 2012-05-01
- Filing Date:
- 2012-05-02
- Accepted Time:
- 2012-05-02 16:00:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1108205 | Curis Inc | CRIS | Biological Products, (No Disgnostic Substances) (2836) | 043505116 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190122 | Mark Noel | 4 Maguire Road Lexington MA 02421 | Vp, Tech Management | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-01 | 36,413 | $1.50 | 63,953 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-05-01 | 36,413 | $4.78 | 27,540 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-05-01 | 37,687 | $1.50 | 65,227 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-05-01 | 37,687 | $4.78 | 27,540 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Qualified stock option (right to buy) | Acquisiton | 2012-05-01 | 36,413 | $1.50 | 36,413 | $1.50 |
Common Stock | Non-qualified stock option (right to buy) | Acquisiton | 2012-05-01 | 37,687 | $1.50 | 37,687 | $1.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2006-06-05 | 2012-06-05 | No | 4 | M | Direct |
0 | 2006-06-05 | 2012-06-05 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 30, 2012.
- These shares were sold between $4.65-$4.89/share. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
- Options vested over a four-year period and became fully vested on June 5, 2006.